Lixte Biotechnology Holdings, I (LIXT) Financials
LIXT Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 5.2 million | 311736 |
2023-06-30 | 3.1 million | 402614 |
2023-03-31 | 4.3 million | 249987 |
2022-12-31 | 5.6 million | 394786 |
LIXT Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -944389 | 112106 |
2023-06-30 | -1.2 million | 280060 |
2023-03-31 | -1.3 million | 276980 |
2022-12-31 | -1.2 million | 385391 |
LIXT Net Income
No data available :(
LIXT Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 5.1 million | - | - |
2023-06-30 | 2.9 million | - | - |
2023-03-31 | 4.1 million | - | - |
2022-12-31 | 5.4 million | - | - |
LIXT Shares Outstanding
LIXT Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | 132487 | 534013 | - |
2023-06-30 | - | 427457 | 862571 | - |
2023-03-31 | - | 189085 | 1.2 million | - |
2022-12-31 | - | 453620 | 1.2 million | - |
LIXT Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | - |
2023-06-30 | - | - |
2023-03-31 | - | - |
2022-12-31 | - | - |
LIXT
Price: $2.85
52 week price:
Earnings Per Share: -2.66 USD
P/E Ratio: -0.64
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 110300
Market Capitalization: 7.6 million